TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
STRONG BUY
A great buy at these levels. 12X earnings is cheap. Has been tarred with the financial brush, largely unjustifiably so. 2.5% dividend is solid and probably goes up by the end of 08. The $500 million that they invested in the CIBC (CM-T) was an interesting play and they got it at a very good price.
DON'T BUY
Would prefer an insurer to a bank right now. Wait for the dust to settle a little bit more on the financials.
COMMENT
Has come off sharply because it is a financial. She is looking at this one very closely. Canadian insurance does not have a big exposure to subprimes and mortgage debacles. We'll be in a trading range until people have little bit more confidence. She thinks the catalyst could be a major acquisition. Strong balance sheet.
COMMENT
Gun down to around $37 last August and is now at the same level. The yellow light has to be on. If it breaks below that level be careful.
BUY
This is a world-class Canadian financial company. Through the John Hancock takeover, they have turned themselves into the 2nd biggest insurer in North America. Have expanded into Asia.
TOP PICK
Trading at 13X earnings. ROE in the mid-to high teens. International growth as well as domestic. $45 plus dividend gives you 15%. Nice safe place to be.
BUY
Likes their China exposure.
BUY
Owns both Manulife (MFC-T) and Sun Life (SLF-T) but has steered his focus to Manulife because PE ratio based on 08 earnings is roughly the same. Would buy both companies equally.
BUY
Did very well but got ahead of itself. Now back into a Buying range. Well-run company. Making great strides in the Far East.
DON'T BUY
Feels that a lot of money has left the banks and money managers to move into the lifecos. It means that companies such as Sun Life (SLF-T), Great West (GWO-T) and Manufacturers (MFC-T) have caught up to the peak of and are exceeding their FMV.
TOP PICK
Chart looks like it is trading all over the map but is actually around $40. In these volatile markets you need stocks that are not all hot.
HOLD
A lot of institutional investors made a shift away from banks and into insurance companies. They have nice international exposure. Decent size and good operator.
BUY
On his Buy list is an equal holding of Manufacturers Life (MFC-T) and Sun Life (SLF-T). ROE on ManuLife is superior. Prefers insurance companies over banks.
BUY
Either Sun Life (SLF-T) or Manufacturers Life (MFC-T) is a good buy at this time. Good yield at 2.3%. Good earnings profile going forward going from $2.51 to about $2.80 this year and perhaps over $3 next year. Making very large inroads and strong market share gains in wealth management.
BUY
Lifecos in the US have gone way up as the banks have gone way down. Lifecos are great stocks to own if you are a value, long-term investor. The stock is cheap and has a good dividend yield. Think they will do much better than the banks in the next year or two.
Showing 1,756 to 1,770 of 2,283 entries